COVID-19 VACCINE SAFETY IN PATIENTS WITH MYASTHENIA GRAVIS
Publication
, Conference
Li, Y; Muppidi, S; Raja, SM; Masterson, S; Huff, W; Karatz, T; Guptill, JT
Published in: MUSCLE & NERVE
2022
Duke Scholars
Published In
MUSCLE & NERVE
EISSN
1097-4598
ISSN
0148-639X
Publication Date
2022
Volume
65
Start / End Page
S31 / S31
Related Subject Headings
- Neurology & Neurosurgery
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Li, Y., Muppidi, S., Raja, S. M., Masterson, S., Huff, W., Karatz, T., & Guptill, J. T. (2022). COVID-19 VACCINE SAFETY IN PATIENTS WITH MYASTHENIA GRAVIS. In MUSCLE & NERVE (Vol. 65, pp. S31–S31).
Li, Yingkai, Srikanth Muppidi, Shruti M. Raja, Samantha Masterson, Wendi Huff, Tabitha Karatz, and Jeffrey T. Guptill. “COVID-19 VACCINE SAFETY IN PATIENTS WITH MYASTHENIA GRAVIS.” In MUSCLE & NERVE, 65:S31–S31, 2022.
Li Y, Muppidi S, Raja SM, Masterson S, Huff W, Karatz T, et al. COVID-19 VACCINE SAFETY IN PATIENTS WITH MYASTHENIA GRAVIS. In: MUSCLE & NERVE. 2022. p. S31–S31.
Li, Yingkai, et al. “COVID-19 VACCINE SAFETY IN PATIENTS WITH MYASTHENIA GRAVIS.” MUSCLE & NERVE, vol. 65, 2022, pp. S31–S31.
Li Y, Muppidi S, Raja SM, Masterson S, Huff W, Karatz T, Guptill JT. COVID-19 VACCINE SAFETY IN PATIENTS WITH MYASTHENIA GRAVIS. MUSCLE & NERVE. 2022. p. S31–S31.
Published In
MUSCLE & NERVE
EISSN
1097-4598
ISSN
0148-639X
Publication Date
2022
Volume
65
Start / End Page
S31 / S31
Related Subject Headings
- Neurology & Neurosurgery
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences